Níl an doiciméad seo ar fáil i do theanga féin. Roghnaítear teanga eile as na teangacha atá ar fáil.

 Innéacs 
 Ar ais 
 Ar aghaidh 
 Téacs iomlán 
Nós Imeachta : 2018/2782(RSP)
Céimeanna an doiciméid sa chruinniú iomlánach
Na doiciméid roghnaithe :

Téacsanna arna gcur síos :

O-000134/2018 (B8-0006/2019)

Díospóireachtaí :

PV 12/02/2019 - 22
CRE 12/02/2019 - 22

Vótaí :

Téacsanna arna nglacadh :


Minutes
Tuesday, 12 February 2019 - Strasbourg

22. Policy challenges and strategies against women's cancers and related comorbidities (debate)
Tuarascálacha focal ar fhocal

Question for oral answer (O-000134/2018) by Daniela Aiuto, on behalf of the FEMM Committee, to the Commission: Policy challenges and strategies against women's cancers and related comorbidities (B8-0006/2019)

Daniela Aiuto moved the question.

IN THE CHAIR: Mairead McGUINNESS
Vice-President

Vytenis Povilas Andriukaitis (Member of the Commission) answered the question.

The following spoke: Marijana Petir, on behalf of the PPE Group, Biljana Borzan, on behalf of the S&D Group, Jana Žitňanská, on behalf of the ECR Group, Lieve Wierinck, on behalf of the ALDE Group, Ángela Vallina, on behalf of the GUE/NGL Group, Agnieszka Kozłowska-Rajewicz, Jadwiga Wiśniewska, Michaela Šojdrová and Francis Zammit Dimech.

The following spoke under the catch-the-eye procedure: Anna Záborská, Julie Ward, Notis Marias, Ana Miranda, Stanislav Polčák, Soledad Cabezón Ruiz and Dubravka Šuica

The following spoke: Vytenis Povilas Andriukaitis.

Motion for a resolution to wind up the debate tabled under Rule 128(5):

—   Daniela Aiuto, on behalf of the FEMM Committee, on policy challenges and strategies against women’s cancers and related comorbidities (2018/2782(RSP)) (B8-0097/2019).

The debate closed.

Vote: minutes of 13.2.2019, item 16.10.

An nuashonrú is déanaí: 12 Márta 2020Fógra dlíthiúil - Beartas príobháideachais